findmyKOL
Clinical trialNCT06904482RecruitingPhase 2Interventional

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

SponsorCase Comprehensive Cancer CenterEnrollment36Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic SyndromesaGVHD
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Leland Metheny, MD

    Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center

    Cleveland, Ohio, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Aug 2025
Primary completion
24 Feb 2027
Completion
25 Feb 2030
Last update posted
27 Feb 2026
Registered enrollment
36
Registry id
NCT06904482

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.